Thoughts for the coming week?, page-134

First 134 Last

Share
Profile

Follow
dazzaa

6,543 Posts.

12

09/10/15

10:26

Post #: 16143536
Share

Originally posted by bbuster ↑

Ok if i was dazza. I think he would say something like this:
Firstly it needs to be stated that do your own trading its your own responsibility

terrible when you know your coy is feeding the manipulators,but to what purpose,is it to sell small amounts into a big ann in doing so you are funding the pump again against resistance levels,look at the past pump and see the gains and how much it costs to pump up the volume so selling to make profit pays the way.When you take away the pump from stack you can see how buyers drop off at a quick rate,so the next leg up will cost a bit i presume.You have to take the fact we know whats coming and see how when you add that to today it does not make sense.Look at that report and think when this coy puts that into a glossy show its going to have impact,and the push to$ 1 is expensive.Otherwise its the old make money game but the last rise was all about buying not selling so the push to $ 1 is and will be funded now and i will check how much % we have lost against gains,plus we broke an amazing resistance level prior to this ,2 in fact.

Detailed Quote - Past 5 WeeksDaily Quotes Weekly Quotes Monthly Quotes
Date Open High Low Last Change % Change Volume
10/05/15 0.495 0.610 0.460 0.585 +0.080 +15.84% 8,322,401
09/28/15 0.455 0.510 0.390 0.505 +0.145 +40.28% 6,481,889
09/21/15 0.170 0.360 0.165 0.360 +0.190 +111.76% 3,509,789
09/14/15 0.175 0.180 0.165 0.170 -0.005 -2.86% 399,422
09/07/15 0.175 0.190 0.165 0.175 unch unch 284,78

what i'm trying to work out for every % percentage rise what % retrace on the s/p we end up with to fund the pumps

The s/p needs to sit at $1.50 for protection of asset.So they may be using the market to get there.

so we have 180% increase and now we have a 20% decrease so by seeing the big picture we get a grip on when to hold and when to sell.I can not sell because of capital gains until jan at least but for some of you the possibility is there to trade the trade.

But once again do your own research

Expand

Please re read this and form your opinion today if this is the case to any pattern as next pump up it says resistance levels can break again.

LOM Price at posting: 52.0¢ Sentiment: Buy Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

There are more pages in this discussion • 4 more messages in this thread...

First 134 Last

Add LOM (ASX) to my watchlist

(20min delay)
Last 4.2¢		Change -0.001(2.33%)		Mkt cap ! $12.47M

Open	High	Low	Value	Volume
4.3¢	4.3¢	4.2¢	$6.548K	154.9K

Buyers (Bids)

No.	Vol.	Price($)
1	240000	4.1¢

Sellers (Offers)

Price($)	Vol.	No.
4.4¢	126495	2

View Market Depth

No.	Vol.	Price($)
1	240000	0.041
1	90000	0.040
4	537871	0.039
3	197211	0.036
3	381414	0.035

Price($)	Vol.	No.
0.044	126495	2
0.045	38400	2
0.046	181600	2
0.047	124900	2
0.048	150000	1

Last trade - 11.08am 04/10/2024 (20 minute delay)

LOM (ASX) Chart

Thoughts for the coming week?, page-134

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Thoughts for the coming week?, page-134

Top Stories

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News